IPP Bureau

GeneStore launches Centre of Excellence in Gurugram, India
GeneStore launches Centre of Excellence in Gurugram, India

By IPP Bureau - May 01, 2022

Center of Excellence for Molecular Diagnostics and Proteomics will enable affordable diagnostics for infectious diseases in India

Once-weekly icodec demonstrates superior reduction in HbA1c vs degludec
Once-weekly icodec demonstrates superior reduction in HbA1c vs degludec

By IPP Bureau - April 29, 2022

In the trial, there was no statistical difference in estimated hypoglycaemia rates, and no severe hypoglycaemia events were observed for people treated with insulin icodec

Ultomiris approved in the US for adults with generalised myasthenia gravis
Ultomiris approved in the US for adults with generalised myasthenia gravis

By IPP Bureau - April 29, 2022

Ultomiris showed early effect and lasting improvement in activities of daily living and has potential to reduce treatment burden with dosing every 8 weeks

Moderna files for authorization of its Covid-19 vaccine in young children six months to six years
Moderna files for authorization of its Covid-19 vaccine in young children six months to six years

By IPP Bureau - April 29, 2022

Submission to regulators globally is based on phase 2/3 studies of mRNA-1273 in young children

Philips and Prisma Health sign multi-year, long-term strategic partnership
Philips and Prisma Health sign multi-year, long-term strategic partnership

By IPP Bureau - April 29, 2022

South Carolina’s largest health system adopts Philips software solutions for patient monitoring and enterprise imaging, helping to drive interoperability and data analytics, and deliver on Quadruple Aim

Camzyos is the first and only USFDA-approved cardiac myosin inhibitor
Camzyos is the first and only USFDA-approved cardiac myosin inhibitor

By IPP Bureau - April 29, 2022

Approval based on groundbreaking Phase 3 EXPLORER-HCM trial demonstrating benefit in patients receiving Camzyos versus placebo

Lilly's tirzepatide delivered up to 22.5% weight loss in adults with obesity
Lilly's tirzepatide delivered up to 22.5% weight loss in adults with obesity

By IPP Bureau - April 29, 2022

Participants taking tirzepatide lost up to 52 lb. (24 kg) in this 72-week phase 3 study

AstraZeneca expands its ‘Young Health Program’ in Delhi
AstraZeneca expands its ‘Young Health Program’ in Delhi

By IPP Bureau - April 29, 2022

For over a decade, AstraZeneca and Plan India’s Young Health Program have been generating awareness and identifying sustainable solutions to influence the behaviour of youths against Non-Communicable Diseases

Lupin Diagnostics launches reference laboratory in Guwahati, Assam
Lupin Diagnostics launches reference laboratory in Guwahati, Assam

By IPP Bureau - April 29, 2022

It is expanding the diagnostics business footprint in North East India

Medikabazaar teams up with India Health Link
Medikabazaar teams up with India Health Link

By IPP Bureau - April 29, 2022

To extend the nationwide distribution network for the availability of its proprietary & award-winning HPod for corporates & doctors’ clinics, thereby strengthening India’s phygital wellness ecosystem

Ami Organics earmarks Rs 190 cr to expand API production in Ankleshwar
Ami Organics earmarks Rs 190 cr to expand API production in Ankleshwar

By IPP Bureau - April 29, 2022

The plant is expected to start commercial operations from Q4FY24

Ceryx Medical raises £3.8m in seed funding to bring cardiac device to in-human trials
Ceryx Medical raises £3.8m in seed funding to bring cardiac device to in-human trials

By IPP Bureau - April 28, 2022

Cysoni is a bionic device that paces the heart with real-time respiratory modulation

Dr Vijay Shetty creates an alternative to x-ray examination
Dr Vijay Shetty creates an alternative to x-ray examination

By IPP Bureau - April 28, 2022

The procedure, named 'Shetty Test' after its creator, could change the way suspected fractures are treated

Beta Drugs announces oultook for FY 22-23
Beta Drugs announces oultook for FY 22-23

By IPP Bureau - April 28, 2022

The management believes that its strong product pipeline, diversified innovative product portfolio, continued expansion into new geographies and FGMP accreditations will help sustain the growth momentum in the coming few years

Cipla bags Pharma Leader of the Year award
Cipla bags Pharma Leader of the Year award

By IPP Bureau - April 28, 2022

Glenmark Pharmaceuticals won Innovation of the Year award

Latest Stories

Interviews

Packaging